Chemotherapy of skull base chordoma tailored on responsiveness of patient-derived tumor cells to rapamycin

Medicine and Dentistry

• Chordoma 100%
• Chemotherapy 54%
• Rapamycin 54%
• Patient 36%
• Cells 36%
• Tumor Cell 27%
• Follow up 18%
• Xenograft 18%
• Neoplasm 18%
• Signal Transduction 18%
• Neuroimaging 18%
• Phenotype 9%
• Combination Therapy 9%
• Tumor Progression 9%
• Cell Proliferation 9%
• Histology 9%
• Growth Rate 9%
• Immunohistochemistry 9%
• Radiation Therapy 9%
• Cell Marker 9%
• Growth 9%
• Gene 9%
• Tumor Cell Line 9%
• Tumor Xenograft 9%
• Carcinogenicity 9%
• Phosphotransferase Inhibitor 9%
• Mechanistic Target of Rapamycin 9%
• Therapeutic Procedure 9%
• Donor 9%
• Cell Line 9%
• Skull Base 9%
• Base of Skull 9%

Neuroscience

• Chordoma 100%
• Chemotherapy 27%
• In Vivo 18%
• Cell Signaling 18%
• Cell Line 18%
• Brachyury 18%
• Skull Base 18%
• Phenotype 9%
• Histology 9%
• Cell Proliferation 9%
• Immunohistochemistry 9%
• Gene 9%
• Kinase 9%
• Mammalian Target of Rapamycin 9%

Pharmacology, Toxicology and Pharmaceutical Science

• Chordoma 100%
• Western Blot 27%
• Neoplasm 18%
• Tumor Growth 9%
• Phosphotransferase Inhibitor 9%
• Carcinogenicity 9%
• Mammalian Target of Rapamycin 9%
• Cell Marker 9%
• Mouse 9%